These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26600018)

  • 1. Voluntary Exercise Stabilizes Established Angiotensin II-Dependent Atherosclerosis in Mice through Systemic Anti-Inflammatory Effects.
    Pellegrin M; Aubert JF; Bouzourène K; Amstutz C; Mazzolai L
    PLoS One; 2015; 10(11):e0143536. PubMed ID: 26600018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability.
    Pellegrin M; Bouzourène K; Aubert JF; Nahimana A; Duchosal MA; Mazzolai L
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30181481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions.
    Pellegrin M; Szostak J; Bouzourène K; Aubert JF; Berthelot A; Nussberger J; Laurant P; Mazzolai L
    J Cardiovasc Pharmacol Ther; 2017 Mar; 22(2):159-168. PubMed ID: 27246357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Training-induced anti-atherosclerotic effects are associated with increased vascular PPARgamma expression in apolipoprotein E-deficient mice.
    Szostak J; Miguet-Alfonsi C; Berthelot A; Laurant P
    Acta Physiol (Oxf); 2016 Feb; 216(2):221-30. PubMed ID: 26467845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
    Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
    Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swimming prevents vulnerable atherosclerotic plaque development in hypertensive 2-kidney, 1-clip mice by modulating angiotensin II type 1 receptor expression independently from hemodynamic changes.
    Pellegrin M; Alonso F; Aubert JF; Bouzourene K; Braunersreuther V; Mach F; Haefliger JA; Hayoz D; Berthelot A; Nussberger J; Laurant P; Mazzolai L
    Hypertension; 2009 May; 53(5):782-9. PubMed ID: 19349555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous angiotensin II enhances atherogenesis in apoprotein E-deficient mice with renovascular hypertension through activation of vascular smooth muscle cells.
    Heo HJ; Yun MR; Jung KH; Lee JY; Park JY; Lee SJ; Bae SS; Lee WS; Kim CD
    Life Sci; 2007 Feb; 80(11):1057-63. PubMed ID: 17204292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice.
    Fraga-Silva RA; Montecucco F; Costa-Fraga FP; Nencioni A; Caffa I; Bragina ME; Mach F; Raizada MK; Santos RAS; da Silva RF; Stergiopulos N
    Vascul Pharmacol; 2015 Nov; 74():103-113. PubMed ID: 26304699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis.
    El Hadri K; Mahmood DF; Couchie D; Jguirim-Souissi I; Genze F; Diderot V; Syrovets T; Lunov O; Simmet T; Rouis M
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1445-52. PubMed ID: 22516068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques.
    Harmon EY; Fronhofer V; Keller RS; Feustel PJ; Zhu X; Xu H; Avram D; Jones DM; Nagarajan S; Lennartz MR
    J Am Heart Assoc; 2014 Dec; 3(6):e001232. PubMed ID: 25516435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
    Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
    Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
    Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voluntary exercise decreases atherosclerosis in nephrectomised ApoE knockout mice.
    Shing CM; Fassett RG; Peake JM; Coombes JS
    PLoS One; 2015; 10(3):e0120287. PubMed ID: 25799529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.
    Erbel C; Akhavanpoor M; Okuyucu D; Wangler S; Dietz A; Zhao L; Stellos K; Little KM; Lasitschka F; Doesch A; Hakimi M; Dengler TJ; Giese T; Blessing E; Katus HA; Gleissner CA
    J Immunol; 2014 Nov; 193(9):4344-55. PubMed ID: 25261478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse.
    Krishna SM; Seto SW; Jose RJ; Biros E; Moran CS; Wang Y; Clancy P; Golledge J
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):389-98. PubMed ID: 25524772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
    Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
    Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice.
    Nogueira BV; Peotta VA; Meyrelles SS; Vasquez EC
    Arch Med Res; 2007 Nov; 38(8):816-21. PubMed ID: 17923260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.